Capricor Therapeutics Inc (CAPR) Stock is looking to regain its victory
Cantor Fitzgerald raised the price target for the Capricor Therapeutics Inc (NASDAQ:CAPR) stock to “an Overweight”. The rating was released on January 05, 2024, according to finviz. The stock was reiterated by H.C. Wainwright, who disclosed in a research note on January 26, 2018, to Buy and set the price objective to $8.60. In their […]
Capricor Therapeutics Inc (NASDAQ:CAPR) stock is trading -34.19 percent below its 52-week high
Cantor Fitzgerald raised the price target for the Capricor Therapeutics Inc (NASDAQ:CAPR) stock to “an Overweight”. The rating was released on January 05, 2024, according to finviz. The stock was reiterated by H.C. Wainwright, who disclosed in a research note on January 26, 2018, to Buy and set the price objective to $8.60. In their […]
Capricor Therapeutics Inc (CAPR) Stock offers help to cash-strapped investors
Cantor Fitzgerald raised the price target for the Capricor Therapeutics Inc (NASDAQ:CAPR) stock to “an Overweight”. The rating was released on January 05, 2024, according to finviz. The stock was reiterated by H.C. Wainwright, who disclosed in a research note on January 26, 2018, to Buy and set the price objective to $8.60. In their […]
Facts about Capricor Therapeutics Inc (CAPR) Stock that you might not know
Cantor Fitzgerald raised the price target for the Capricor Therapeutics Inc (NASDAQ:CAPR) stock to “an Overweight”. The rating was released on January 05, 2024, according to finviz. The stock was reiterated by H.C. Wainwright, who disclosed in a research note on January 26, 2018, to Buy and set the price objective to $8.60. In their […]
